Work

Successful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus

Year: 2024

Type: article

Abstract: Lupus erythematosus (LE) is a chronic, multisystem autoimmune disorder which presents with varying phenotypic findings depending on organ involvement. LE subgroups include neonatal lupus erythematosus, drug-induced lupus, systemic lupus erythematosus (SLE), and cutaneous lupus erythematosus (CLE).1,2 CLE may occur in association with or independent of SLE. CLE is further classified into 3 LE-specific cutaneous subtypes based on unique clinical features, histopathology, and immunologic characteristics.

Source: JAAD Case Reports

DOI: 10.1016/j.jdcr.2024.11.014

Authors: Bishoy Abdelmalik, Steven Svoboda, Pooja Gurnani, Kiran Motaparthi

Institutions: University of Florida Health, University of Florida

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $750